AbbVie bets $10.9 billion on Apogee in next-generation immunology growth push - Reuters
AbbVie bets $10.9 billion on Apogee in next-generation immunology growth push Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
All Coverage
<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxNdHUwZ3V2VWJfMjNDSjJEV0NkdHJBZTQ1dFQ0Y1FjdGY1NGsxZFdMbXo1N01Vei05R3dGZTN5MEFlcGJZc3Rmajh0dkZacmNCM2ZUZTVYMTM3TlZTVXNNOWRCVXg4dVkwRnBIUU1yT19ObnhJbW42eXU0OU1tNHgtQmZsZS1SR2RjMUJBanBLX3hCWFBIOS1XRDFGOTgzdW9kaHdzREN1dw?oc=5" target="_blank">AbbVie bets $10.9 billion on Apogee in next-generation immunology growth push</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom - Reuters
Nvidia-backed Iambic Therapeutics launches IPO as biotechs buck market gloom Reuters
October 8, 2026 at 06:18 PMViatris bets on non-opioid pain drugs with $1.65 billion Pacira deal - Reuters
Viatris bets on non-opioid pain drugs with $1.65 billion Pacira deal Reuters
October 8, 2026 at 02:39 PMEXCLUSIVE: Refresco plots potential IPO at $10 billion-plus valuation, sources say - Reuters
EXCLUSIVE: Refresco plots potential IPO at $10 billion-plus valuation, sources say Reuters
October 8, 2026 at 09:37 PMApplied Digital's revenue soars, loss widens on growing AI investments - Reuters
Applied Digital's revenue soars, loss widens on growing AI investments Reuters
October 7, 2026 at 09:23 PMBecton Dickinson pledges $19 billion US investment in deal with government - Reuters
Becton Dickinson pledges $19 billion US investment in deal with government Reuters
October 6, 2026 at 03:06 PMMcKesson, CD&R to take infusion therapy provider Option Care private in $5.8 billion deal - Reuters
McKesson, CD&R to take infusion therapy provider Option Care private in $5.8 billion deal Reuters
October 6, 2026 at 04:30 PM